[{"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-001", "question": "A 65-year-old woman with Crohn's disease undergoes ileocecal resection. Pathology shows transmural inflammation and non-caseating granulomas. Postoperatively, she develops recurrent diarrhea and weight loss. What is the most likely complication?", "options": ["Short bowel syndrome", "Anastomotic stricture", "Bacterial overgrowth", "Vitamin B12 deficiency", "Bile acid malabsorption"], "answer": "E", "answer_index": 4, "explanation": "Resection of the terminal ileum in Crohn's disease disrupts bile acid reabsorption, leading to bile acid malabsorption and diarrhea. Short bowel syndrome requires more extensive resection. Vitamin B12 deficiency may occur but typically presents later with anemia, not acute diarrhea.", "generator_model": "grok-4-0709", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed130", "source_question_id": "20251216T182308874Z_grok-4-0709_seed130-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed130.jsonl", "pred": "E", "model_outputs": "This question describes a patient with Crohn's disease who has undergone an ileocecal resection and subsequently presents with recurrent diarrhea and weight loss.\n\nAnalysis:\n1.  Anatomy and Physiology: The terminal ileum (removed in an ileocecal resection) is the specialized site for the reabsorption of bile acids and Vitamin B12.\n2.  Pathophysiology: When the terminal ileum is resected, bile acids are not reabsorbed and pass into the colon.\n    *   If the resection is short (< 100 cm), unabsorbed bile acids irritate the colonic mucosa, stimulating the secretion of water and electrolytes, leading to secretory diarrhea (choleretic diarrhea).\n    *   If the resection is extensive (> 100 cm), the loss of bile acids exceeds the liver's ability to synthesize new ones, leading to a depleted bile acid pool. This results in fat malabsorption (steatorrhea), which causes both diarrhea and weight loss.\n3.  Evaluating Options:\n    *   A. Short bowel syndrome: This typically requires a much larger resection of the small bowel resulting in intestinal failure. An isolated ileocecal resection does not usually cause frank short bowel syndrome unless there were previous extensive resections.\n    *   B. Anastomotic stricture: This would present with symptoms of bowel obstruction (nausea, vomiting, abdominal distention, cramping pain), not primarily secretory diarrhea.\n    *   C. Bacterial overgrowth: While removal of the ileocecal valve is a risk factor for Small Intestinal Bacterial Overgrowth (SIBO), bile acid malabsorption is the direct physiological consequence of removing the absorptive surface for bile acids.\n    *   D. Vitamin B12 deficiency: While this will occur due to the loss of the terminal ileum, it takes years to develop because of hepatic stores. Furthermore, it presents with megaloblastic anemia and neurologic deficits, not diarrhea.\n    *   E. Bile acid malabsorption: This fits the clinical presentation perfectly. The diarrhea (caused by bile salts in the colon or fat malabsorption) and weight loss (due to malabsorption and rapid transit) are characteristic. This is also known as choleretic enteropathy.\n\nConclusion: The most likely complication explaining the diarrhea and weight loss following ileocecal resection is bile acid malabsorption.\n\nThe answer is (E)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-002", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "source_question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed126", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed126.jsonl", "pred": "B", "model_outputs": "This patient with rheumatoid arthritis (RA) presents with progressive dyspnea and findings of interstitial lung disease (ILD). The key to the diagnosis lies in differentiating between the pulmonary manifestations of the underlying disease (RA) and the potential toxicity of the medication (methotrexate).\n\n1.  Imaging Pattern: The high-resolution CT (HRCT) findings describe \"subpleural reticular opacities and traction bronchiectasis.\" This pattern is characteristic of fibrosis. Specifically, a subpleural and basal predominance of reticulation with traction bronchiectasis (with or without honeycombing) is the hallmark of the Usual Interstitial Pneumonia (UIP) pattern.\n    *   Non-specific interstitial pneumonia (NSIP), the other common pattern in connective tissue diseases, typically presents with ground-glass opacities and reticulation that *spares* the immediate subpleural lung. The absence of ground-glass opacities and the presence of subpleural involvement in the description favor UIP.\n    *   Cryptogenic organizing pneumonia (COP) typically presents with patchy, peripheral consolidations, not subpleural reticulation.\n    *   Hypersensitivity pneumonitis (HP) often presents with centrilobular nodules and mosaic attenuation (air trapping), usually in the upper/mid zones.\n\n2.  Etiology (Drug vs. Disease):\n    *   Methotrexate (MTX) pneumonitis is classically an acute or subacute hypersensitivity reaction. It presents with fever, eosinophilia, and diffuse ground-glass opacities or consolidates on imaging. It is rare for MTX toxicity to present primarily as a chronic, progressive fibrotic process indistinguishable from UIP. Recent large-scale studies suggest MTX main not increase the risk of RA-ILD and may even be protective, reinforcing that the ILD is likely due to the RA itself.\n    *   RA-associated ILD: Interstitial lung disease is a common extra-articular manifestation of RA. Unlike other connective tissue diseases (like scleroderma) where NSIP is the dominant pattern, RA is distinct because the UIP pattern is very common (often cited as the most common or necessitating distinction from Idiopathic Pulmonary Fibrosis).\n\nGiven the clinical presentation of chronic progressive dyspnea and the HRCT evidence of subpleural fibrosis (UIP pattern), the diagnosis is RA-associated ILD with a UIP pattern.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-003", "question": "A 55-year-old immunocompromised patient with lung transplant develops dyspnea and ground-glass opacities on CT. Bronchoalveolar lavage PCR is positive for Pneumocystis jirovecii, but serum beta-D-glucan is negative. He is on trimethoprim-sulfamethoxazole prophylaxis. What explains the breakthrough infection?", "options": ["Dihydropteroate synthase gene mutation", "Non-adherence to prophylaxis", "Concurrent cytomegalovirus co-infection", "Inadequate dosing in obesity", "Atovaquone cross-resistance"], "answer": "A", "answer_index": 0, "explanation": "Mutations in the dihydropteroate synthase gene confer resistance to sulfamethoxazole in Pneumocystis, leading to breakthrough despite prophylaxis in immunocompromised hosts. Non-adherence is common but less likely with negative beta-D-glucan suggesting low burden. CMV co-infection exacerbates but does not cause resistance.", "generator_model": "grok-4-0709", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed124", "source_question_id": "20251201T041413890Z_grok-4-0709_seed124-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed124.jsonl", "pred": "A", "model_outputs": "In this clinical vignette, a lung transplant recipient on trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis develops *Pneumocystis jirovecii* pneumonia (PCP). The diagnosis is supported by symptoms (dyspnea), radiology (GGO), and positive PCR, despite the negative beta-D-glucan (which can occur in HIV-negative immunocompromised patients due to lower fungal burden).\n\nThe question asks for the explanation of the breakthrough infection despite prophylaxis.\n\n*   Option A (Dihydropteroate synthase gene mutation): Sulfamethoxazole (the sulfa component of TMP-SMX) inhibits the enzyme dihydropteroate synthase (DHPS). Mutations in the DHPS gene of *P. jirovecii* confer resistance to sulfonamides. Epidemiological studies have demonstrated a strong association between the presence of DHPS mutations and the failure of sulfa-based prophylaxis (breakthrough infection). In the context of board exams, this is the specific mechanism of resistance tested for PCP breakthrough on TMP-SMX.\n*   Option B (Non-adherence): While a common real-world cause, exam questions typically require identifying a specific pathological or pharmacological mechanism unless social cues suggest otherwise.\n*   Option C (Concurrent CMV): CMV is a risk factor for PCP due to increased immunosuppression, but it does not directly explain the failure of the antibiotic to prevent the specific bacterial/fungal proliferation in the same mechanistic way that resistance does.\n*   Options D & E: There is no evidence of obesity dosing issues presented, and the patient is not on atovaquone.\n\nThe negative serum beta-D-glucan is a distractor or a clinical nuance indicating the lower fungal burden seen in non-HIV PCP (lung transplant recipients), where symptoms result from the host inflammatory response rather than high organism load. However, the confirmed infection (via PCR and clinical context) despite prophylaxis points to antibiotic resistance.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-004", "question": "A 9-year-old girl with neurofibromatosis type 1 presents with hypertension and headaches. MRI reveals a pheochromocytoma and bilateral renal artery stenosis. Genetic analysis confirms NF1 mutation. What is the most appropriate initial management for her hypertension prior to surgical intervention?", "options": ["Alpha-blockade with phenoxybenzamine followed by beta-blockade", "Angiotensin-converting enzyme inhibitor monotherapy", "Percutaneous renal artery angioplasty", "Calcium channel blocker initiation", "Surgical resection of pheochromocytoma without preoperative preparation"], "answer": "A", "answer_index": 0, "explanation": "In pheochromocytoma associated with NF1, preoperative alpha-blockade followed by beta-blockade is essential to prevent hypertensive crisis during surgery. ACE inhibitors may exacerbate renal stenosis issues, and angioplasty or surgery without preparation risks catecholamine surge. Calcium channel blockers are not sufficient alone.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The patient presents with hypertension due to two potential etiologies associated with Neurofibromatosis type 1: a pheochromocytoma and bilateral renal artery stenosis.\n\nThe management priority is to safely control blood pressure and prevent a hypertensive crisis, particularly during induction of anesthesia or surgical manipulation. Of the two conditions, the pheochromocytoma poses the most immediate risk for a life-threatening catecholamine surge.\n\n1.  Safety First: Performing any invasive procedure (like renal angioplasty) or surgery without blocking the effects of the catecholamines from the pheochromocytoma can precipitate a hypertensive crisis, arrhythmia, and death. Therefore, the pheochromocytoma must be managed medically before any intervention.\n2.  Medical Management of Pheochromocytoma: The standard preoperative preparation involves alpha-adrenergic blockade (e.g., phenoxybenzamine). This allows for expansion of intravascular volume (which is typically contracted due to vasoconstriction) and controls blood pressure. Once alpha-blockade is established, beta-adrenergic blockade is added if necessary to control tachycardia. Giving a beta-blocker *before* an alpha-blocker is contraindicated because it can lead to \"unopposed alpha stimulation,\" causing worsening vasoconstriction and hypertension.\n3.  Contraindications in this case:\n    *   ACE inhibitors (Option B): These are usually contraindicated or used with extreme caution in patients with *bilateral* renal artery stenosis because they can significantly reduce glomerular filtration rate and precipitate acute renal failure.\n    *   Percutaneous renal artery angioplasty (Option C): This is an invasive procedure that could trigger a catecholamine release; the patient must be medically blockaded first.\n    *   Immediate Surgery (Option E): Extremely dangerous due to the risk of hypertensive crisis.\n\nTherefore, the correct initial step represents the standard preoperative protocol for pheochromocytoma.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-005", "question": "In the emergency department, a 50-year-old man presents with severe abdominal pain and vomiting. CT scan shows acute pancreatitis with necrosis. He develops hypotension and acute kidney injury. Serum triglycerides are 1200 mg/dL. What is the most appropriate initial management for the hypertriglyceridemia?", "options": ["Plasmapheresis", "Insulin infusion", "Fibrates", "Niacin", "Statins"], "answer": "B", "answer_index": 1, "explanation": "Insulin infusion effectively lowers triglycerides in hypertriglyceridemic pancreatitis by enhancing lipoprotein lipase activity. Plasmapheresis is reserved for severe cases not responding to insulin. Fibrates, niacin, and statins are long-term therapies not suitable for acute management.", "generator_model": "grok-4-0709", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251201T041413890Z_grok-4-0709_seed127", "source_question_id": "20251201T041413890Z_grok-4-0709_seed127-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251201T041413890Z_grok-4-0709_seed127", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251201T041413890Z_grok-4-0709_seed127.jsonl", "pred": "A", "model_outputs": "This patient presents with severe acute pancreatitis complicated by organ failure (hypotension and acute kidney injury) and pancreatic necrosis, caused by severe hypertriglyceridemia (levels > 1000 mg/dL).\n\nThe management of hypertriglyceridemia-induced acute pancreatitis (HTG-AP) focuses on reducing serum triglyceride levels to below 500 mg/dL to prevent further pancreatic injury and hasten recovery. The two primary modalities for rapidly lowering triglycerides in the acute setting are plasmapheresis (therapeutic plasma exchange) and intravenous insulin infusion.\n\n*   Plasmapheresis (A): This is the most rapid method for lowering serum triglycerides, capable of removing them within hours. It is also believed to remove inflammatory cytokines. Clinical guidelines and expert consensus (e.g., UpToDate, American Society for Apheresis) typically reserve plasmapheresis for patients with severe pancreatitis characterized by \"worrisome features\" such as hypocalcemia, lactic acidosis, signs of worsening organ dysfunction (SIRS), or multiorgan failure (like obstruction, hypotension,/shock, or AKI). Given this patient's hypotension and AKI, plasmapheresis is the indicated treatment to rapidly reverse the metabolic etiology and manage the cytokine storm.\n\n*   Insulin infusion (B): Intravenous insulin (often with glucose) activates lipoprotein lipase (LPL) and helps lower triglycerides over days. It is the standard initial therapy for patients who are stable and do not present with severe organ failure, or when apheresis is unavailable. While effective, it acts slower than plasmapheresis. Due to the presence of severe complications (necrosis, AKI, hypotension), plasmapheresis is the superior choice in theoretical \"best management\" exam scenarios.\n\n*   Fibrates (C), Niacin (D), and Statins (E) are oral agents used for long-term management of chronic hyperlipidemia and are not effective for the rapid reduction of triglycerides required in an acute hypertensive pancreatic crisis.\n\nTherefore, given the severity of the presentation with organ failure, plasmapheresis is the most appropriate initial management for the hypertriglyceridemia.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-006", "question": "A 29-year-old woman with polycystic ovary syndrome undergoes in vitro fertilization and develops abdominal distension, dyspnea, and oliguria 5 days post-embryo transfer. Ultrasound shows massive ascites and enlarged ovaries. Laboratory tests reveal hemoconcentration and hyponatremia. What is the most appropriate initial management?", "options": ["Intravenous albumin infusion and paracentesis", "Diuretic therapy with furosemide", "Heparin prophylaxis alone", "Expectant management at home", "Surgical ovarian detorsion"], "answer": "A", "answer_index": 0, "explanation": "Severe ovarian hyperstimulation syndrome requires fluid management with albumin for oncotic pressure and paracentesis for symptomatic relief. Diuretics worsen hypovolemia; heparin prevents thrombosis but is adjunctive. Expectant management risks deterioration; detorsion is for torsion, not OHSS.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "target_topic", "source_label_raw": "Obstetrics and Gynecology", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-016", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The clinical presentation describes a patient with severe Ovarian Hyperstimulation Syndrome (OHSS), characterized by massive ascites, enlarged ovaries, hemoconcentration, hyponatremia, dyspnea, and oliguria.\n\n1.  Diagnosis: The combination of IVF history, enlarged ovaries, and third-spacing of fluid (ascites, hemoconcentration) confirms OHSS. The presence of dyspnea, oliguria, and massive ascites classifies it as severe OHSS.\n2.  Pathophysiology: OHSS is driven by vascular endothelial growth factor (VEGF), leading to increased capillary permeability. Fluid shifts from the intravascular space to the extravascular compartments, causing intravascular hypovolemia (hemoconcentration, oliguria) and third-space fluid accumulation (ascites, pleural effusions).\n3.  Management:\n    *   Fluid Resuscitation: The immediate goal is to restore intravascular volume to ensure organ perfusion (kidneys). While crystalloids are the first-line fluid, colloids like intravenous albumin (25%) are frequently used in severe cases to increase oncotic pressure and help retain fluid in the intravascular space, especially when there is significant hypoalbuminemia or when large volumes of ascites are removed.\n    *   Paracentesis: This is indicated in patients with tense ascites causing respiratory compromise (dyspnea), severe pain, or oliguria/renal compromise (due to increased intra-abdominal pressure or \"abdominal compartment syndrome\" impairing renal perfusion). This patient has both dyspnea and oliguria, making paracentesis appropriate to relieve symptoms and improve renal function.\n    *   Thromboprophylaxis: Patients are hypercoagulable, so anticoagulation is necessary, but heparin alone (Option C) addresses only one aspect of risk and does not treat the acute hemodynamic and respiratory crisis.\n    *   Contraindications: Diuretics (Option B) are contraindicated initially because the patient is intravascularly volume depleted; they would worsen hemoconcentration and renal failure. Surgical intervention (Option E) is reserved for ovarian torsion or rupture; surgery on enlarged, friable ovaries without these complications carries a high risk of hemorrhage and ovarian loss. Home management (Option D) is inappropriate for severe OHSS requiring aggressive monitoring and intervention.\n\nTherefore, the combination of supporting intravascular volume (albumin) and relieving mechanical pressure from ascites (paracentesis) is the best option provided.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-007", "question": "A 32-year-old woman with schizophrenia on clozapine develops fever, tachycardia, and muscle rigidity. Laboratory findings include elevated creatine kinase and leukocytosis. Which rare adverse effect is most likely responsible, and what is the next step in management?", "options": ["Agranulocytosis; discontinue clozapine and start G-CSF", "Neuroleptic malignant syndrome; administer dantrolene and bromocriptine", "Serotonin syndrome; give cyproheptadine", "Catatonia; initiate electroconvulsive therapy", "Myocarditis; perform echocardiography and stop clozapine"], "answer": "B", "answer_index": 1, "explanation": "Neuroleptic malignant syndrome is the diagnosis, requiring immediate supportive care with dantrolene for rigidity and bromocriptine for dopamine agonism. Agranulocytosis presents with infection without rigidity, serotonin syndrome lacks CK elevation typically, catatonia is behavioral, and myocarditis involves cardiac symptoms primarily.", "generator_model": "grok-4-0709", "seed": 129, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed129", "source_question_id": "20251216T182308874Z_grok-4-0709_seed129-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed129", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed129.jsonl", "pred": "B", "model_outputs": "Based on the clinical presentation, the patient is exhibiting the classic signs of Neuroleptic Malignant Syndrome (NMS).\n\n1.  Diagnosis: NMS is a rare but life-threatening idiosyncratic reaction to antipsychotic drugs (neuroleptics), including atypical antipsychotics like clozapine. It is characterized by the tetrad of:\n    *   Fever (often high).\n    *   Muscle rigidity (often described as \"lead-pipe\").\n    *   Autonomic instability (e.g., tachycardia, labile blood pressure).\n    *   Altered mental status.\n    *   Laboratory findings: Elevated creatine kinase (CK) due to muscle rigidity/rhabdomyolysis and leukocytosis are hallmark laboratory abnormalities associated with NMS.\n\n2.  Differential Diagnosis:\n    *   Agranulocytosis (A): This is a major concern with clozapine, but it presents with severe leukopenia (low WBC) and increased susceptibility to infection. This patient has leukocytosis (high WBC) and muscle rigidity, which fits NMS, not agranulocytosis.\n    *   Serotonin Syndrome (C): This presents with neuromuscular hyperactivity (hyperreflexia, clonus) rather than the severe \"lead-pipe\" rigidity seen in NMS. It is typically caused by serotonergic agents.\n    *   Catatonia (D): Valid differential (malignant catatonia), but given the recent use of an antipsychotic and the specific constellation of rigidity and elevated CK, NMS is the most precise diagnosis. Treatment often overlaps (benzodiazepines), but NMS specific pharmacotherapy is distinctive in exam contexts.\n    *   Myocarditis (E): A known risk of clozapine manifesting with tachycardia and fever, but it would typically present with chest pain, dyspnea, and elevated troponin/eosinophilia, not generalized muscle rigidity and massive CK elevation.\n\n3.  Management: The immediate steps are to discontinue the offending antipsychotic agent and provide supportive care (hydration, cooling). Pharmacological intervention often includes dantrolene (a muscle relaxant to treat rigidity and hyperthermia) and bromocriptine (a dopamine agonist to restore dopaminergic tone).\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-008", "question": "A 45-year-old man with a history of relapsing-remitting multiple sclerosis presents with acute onset of bilateral leg weakness and urinary retention. MRI shows a new T2-hyperintense lesion at T10 with gadolinium enhancement. Despite high-dose intravenous methylprednisolone, symptoms worsen over 48 hours. CSF analysis reveals elevated IgG index and oligoclonal bands. What is the most appropriate next step in management?", "options": ["Initiate plasma exchange", "Administer rituximab", "Start fingolimod", "Perform lumbar puncture for repeat CSF analysis", "Switch to natalizumab"], "answer": "A", "answer_index": 0, "explanation": "Plasma exchange is the most appropriate next step for severe acute demyelinating attacks unresponsive to corticosteroids in multiple sclerosis, as it rapidly removes circulating autoantibodies and inflammatory mediators. Rituximab and natalizumab are disease-modifying therapies not indicated for acute management, while fingolimod is contraindicated in active inflammation; repeat CSF analysis is unnecessary with established diagnosis.", "generator_model": "grok-4-0709", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "target_topic", "source_label_raw": "Neurology", "source_quiz_id": "20251225T231536524Z_grok-4-0709_seed133", "source_question_id": "20251225T231536524Z_grok-4-0709_seed133-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251225T231536524Z_grok-4-0709_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251225T231536524Z_grok-4-0709_seed133.jsonl", "pred": "A", "model_outputs": "Here is a step-by-step analysis to determine the best answer:\n\n1.  Clinical Scenario: The patient has established relapsing-remitting multiple sclerosis (RRMS) and is currently experiencing an acute, severe relapse (transverse myelitis characterized by bilateral leg weakness and urinary retention).\n2.  Diagnostic Confirmation: MRI confirms a new active lesion at T10 (gadolinium-enhancing), and CSF supports MS (oligoclonal bands).\n3.  Current Treatment Failure: The patient has received high-dose intravenous methylprednisolone (the standard first-line treatment for acute relapses), but his symptoms have worsened over 48 hours. This defines the case as a steroid-refractory relapse.\n4.  Guideline Recommendation: High-dose corticosteroids are the first line of treatment. For patients with acute, severe neurological deficits resulting from demyelinating disease who do not respond to corticosteroids, guidelines (such as those from the American Academy of Neurology) recommend therapeutic plasma exchange (PLEX).\n5.  Evaluating Other Options:\n    *   Rituximab (B), Fingolimod (C), and Natalizumab (E) are disease-modifying therapies (DMTs) used to prevent *future* relapses. They are not indicated as acute rescue therapies for an ongoing, deteriorating attack. While a change in DMT may be warranted after recovery to prevent further progression, it will not address the immediate crisis effectively.\n    *   Repeat Lumbar Puncture (D) is unnecessary as the diagnosis is already established, and it would delay effective treatment.\n\nTherefore, the most appropriate next step for a steroid-refractory acute MS exacerbation is plasma exchange.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-009", "question": "A neonate with congenital diaphragmatic hernia undergoes surgical repair at 48 hours of life. Postoperatively, the infant develops persistent pulmonary hypertension with right-to-left shunting on echocardiography. Despite maximal ventilatory support and inhaled nitric oxide, oxygenation remains poor. What is the most appropriate next step in management?", "options": ["Initiation of extracorporeal membrane oxygenation", "Administration of intravenous milrinone", "High-frequency oscillatory ventilation trial", "Surgical revision of hernia repair", "Prostaglandin E1 infusion"], "answer": "A", "answer_index": 0, "explanation": "ECMO is indicated for refractory pulmonary hypertension in congenital diaphragmatic hernia when conventional therapies fail. Milrinone may help but is not superior to ECMO in severe cases; HFOV is already part of maximal support. Surgical revision or PGE1 is not appropriate without evidence of ductal dependency.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "The clinical scenario describes a neonate with Congenital Diaphragmatic Hernia (CDH) who has undergone repair but is suffering from severe Persistent Pulmonary Hypertension of the Newborn (PPHN). The key descriptors are that the patient has persistent right-to-left shunting and poor oxygenation despite maximal ventilatory support and inhaled nitric oxide (iNO).\n\n1.  Definition of Failure of Medical Management: In the management algorithm for CDH, \"maximal ventilatory support\" typically encompasses the use of High-Frequency Oscillatory Ventilation (HFOV) or optimized conventional ventilation strategies designed to recruit lung volume without causing barotrauma. The addition of inhaled nitric oxide is the standard pharmacologic intervention for PPHN.\n2.  ECMO Criteria: When a neonate with CDH remains hypoxic (poor oxygenation) with persistent PPHN despite these interventions, they meet the criteria for Extracorporeal Membrane Oxygenation (ECMO). Common criteria include an Oxygenation Index (OI) > 40 consistently, acute deterioration, or failure to respond to maximal medical therapy.\n3.  Other Options:\n    *   Milrinone (B): While milrinone is useful in CDH for RV dysfunction and pulmonary vasodilation, it is an adjunctive therapy. If oxygenation is critically poor despite maximal support, waiting for the effect of milrinone is often insufficient, and the patient requires the immediate cardiopulmonary bypass provided by ECMO.\n    *   HFOV trial (C): The phrase \"maximal ventilatory support\" implies that advanced ventilation modes like HFOV have likely already been employed or that the ventilation strategy has been optimized to its limit. If the patient is failing \"maximal\" support, swapping modes is less likely to be the definitive answer compared to ECMO.\n    *   Surgical revision (D): There is no evidence of mechanical failure of the repair (e.g., re-herniation). PPHN is a physiologic consequence, not a surgical one.\n    *   Prostaglandin E1 (E): Used to maintain ductal patency, which can offload the right ventricle in PPHN (acting as a \"pop-off\" valve). While this can support RV function, it leads to systemic desaturation and does not correct the fundamental failure of oxygenation described in a refractory case requiring rescue.\n\nTherefore, the appropriate escalation for a CDH patient with refractory hypoxemia failing maximal medical and ventilatory management is ECMO.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_grok-4-0709_p05", "question_id": "ABMS20260101_grok-4-0709_p05-010", "question": "A 2-year-old boy with hypoplastic left heart syndrome post-Norwood procedure presents with feeding intolerance and metabolic acidosis. Echocardiography shows preserved ventricular function but elevated right atrial pressure. Cardiac catheterization reveals stenosis at the neo-aortic arch. What is the most appropriate intervention?", "options": ["Balloon angioplasty of the arch stenosis", "Surgical arch augmentation", "Fontan completion procedure", "Heart transplantation evaluation", "Medical management with afterload reduction"], "answer": "B", "answer_index": 1, "explanation": "Surgical augmentation is preferred for neo-aortic arch stenosis in HLHS post-Norwood due to better long-term patency than balloon angioplasty, which has high restenosis rates. Fontan is premature; transplantation is for end-stage failure. Medical management does not address the anatomic issue.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "source_question_id": "20251216T182308874Z_grok-4-0709_seed128-011", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/grok-4-0709/20251216T182308874Z_grok-4-0709_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T182308874Z_grok-4-0709_seed128.jsonl", "pred": "A", "model_outputs": "This clinical scenario describes a toddler with Hypoplastic Left Heart Syndrome (HLHS) who has previously undergone the Norwood procedure and now presents with signs of low cardiac output (feeding intolerance, metabolic acidosis) and obstruction of the systemic outflow tract (neo-aortic arch stenosis confirmed by catheterization).\n\n1.  Diagnosis: The patient has recurrent or residual obstruction at the site of the neo-aortic arch reconstruction. This is a known complication following the Norwood procedure.\n2.  Pathophysiology: The stenosis increases the afterload on the single right ventricle. Despite preserved systolic function, the high afterload leads to elevated ventricular end-diastolic pressure, which translates to elevated right atrial pressure. The systemic obstruction compromises perfusion to the gut and lower body, leading to feeding intolerance and metabolic acidosis.\n3.  Management: The treatment goal is to relieve the obstruction to improve systemic perfusion and lower ventricular work/filling pressures.\n    *   Catheter-based intervention (Balloon Angioplasty): For *recurrent* or residual coarctation/arch obstruction following surgical repair (like the Norwood), balloon angioplasty is the generally accepted first-line intervention. It is less invasive than re-operation and effective in relieving the gradient. Stenting may also be utilized in this age group, but balloon angioplasty is the fundamental transcatheter approach listed.\n    *   Surgery (Arch Augmentation): Surgical repair is typically reserved for native coarctation in neonates or for recurrent cases where catheter intervention fails or is anatomically unfeasible. It carries higher morbidity due to the need for repeat sternotomy and cardiopulmonary bypass.\n    *   Fontan Completion: Proceeding to the Fontan procedure is contraindicated in the presence of significant outflow tract obstruction, preserved high ventricular end-diastolic pressure, or elevated pulmonary artery pressures. The obstruction must be corrected first to optimize the hemodynamics for Fontan physiology.\n    *   Heart Transplant: Since ventricular function is preserved, transplantation is not indicated. The issue is mechanical obstruction, not pump failure.\n    *   Medical Management: Inotropic support or afterload reduction does not correct the anatomic stenosis and is insufficient for a patient with metabolic acidosis and signs of shock.\n\nTherefore, the most appropriate intervention is to treat the stenosis in the catheterization lab.\n\nThe answer is (A)"}]